Soleus Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
2,000
-15,000
| -88% | -$1.57M | 0.01% | 93 |
|
|
2025
Q1 | $1.98M | Buy |
+17,000
| New | +$1.98M | 0.14% | 61 |
|
|
2023
Q4 | – | Sell |
-237,500
| Closed | -$16.6M | – | 78 |
|
|
2023
Q3 | $16.6M | Buy |
237,500
+212,600
| +854% | +$14.9M | 1.53% | 21 |
|
|
2023
Q2 | $1.79M | Buy |
24,900
+4,200
| +20% | +$302K | 0.2% | 76 |
|
|
2023
Q1 | $1.28M | Sell |
20,700
-29,300
| -59% | -$1.81M | 0.13% | 69 |
|
|
2022
Q4 | $3.86M | Buy |
+50,000
| New | +$3.86M | 0.55% | 44 |
|